Tirzepatide (available through PlexusDx) showed even greater efficacy in SURPASS trials at up to 22.5% weight loss
Unlike medications that focus on appetite suppression, our challenge combines targeted fitness routines, expert guidance, and real food meal plans to naturally boost your bodys ability to lose weight
API Sourcing and Quality Verification: Patients should ask their compounding pharmacy about active pharmaceutical ingredient (API) sourcing and documentation (such as certificates of analysis) and discuss any quality verification procedures with their prescribing provider
2025 Meta-Analysis: Pooled Evidence A systematic review and meta-analysis published in PMC (2025), pooling 2 RCTs and 5 retrospective cohorts, confirmed tirzepatides superiority with an overall mean difference of 4.23 kg in favour of tirzepatide (95% CI: 3.225.25
These documents are written for clinicians and explain safety concerns clearly
Another phase 2 RCT studying semglutide 2.4 mg vs placebo in patients with compensated NASH cirrhosis did not show any statistically significant difference in NASH resolution or improvement in liver fibrosis between the groups
